Metabolomic Analysis of N -acetylcysteine Protection of Injury from Gadolinium-DTPA Contrast Agent in Rats with Chronic Renal Failure
- 1 September 2017
- journal article
- research article
- Published by SAGE Publications in OMICS: A Journal of Integrative Biology
- Vol. 21 (9) , 540-549
Abstract
Gadolinium-based contrast agents (GBCAs) are frequently used to enhance the diagnostic efficacy of magnetic resonance imaging. On the other hand, the association between GBCA administration in patients with advanced renal disease and nephrogenic systemic fibrosis (NSF) was also noted. NSF is a systemic disorder characterized by widespread tissue fibrosis that may lead to death. N -acetylcysteine (NAC) protects rats from injury induced by gadolinium-based contrast agents, but the underlying mechanisms remain unclear. In this study, a nuclear magnetic resonance-based metabolomic approach was used to systematically investigate the protective effects of NAC on Gd-DTPA-induced injury. Thirty-two male Sprague-Dawley rats were given adenine (200 mg·kg −1 body weight) by oral gavage once a day for 3 weeks to induce chronic renal failure (CRF). NAC (600 mg/L in drinking water for 9 days) pretreatment was initiated 2 days before Gd-DTPA injection (a single tail vein injection, 2 mmol/kg body weight). Serum and liver samples were collected on day 7 after Gd-DTPA injection. By study design, the serum and hepatic metabolic changes of rats were measured in four groups of eight each: CRF, CRF-Gd, CRF-Gd-NAC, and CRF-NAC. Gd-DTPA administration to rats with CRF resulted in disturbances of several metabolic pathways, including glucose, lipid, glutamate, choline, gut microbiota, one-carbon, and purine metabolism. NAC pretreatment reversed the abundance changes of high-density lipoprotein, low-density lipoprotein, very low-density lipoprotein, glutamate, glutamine, oxidized glutathione, choline, phosphocholine, glycerophosphocholine, trimethylamine, and trimethylamine-N-oxide induced by Gd-DTPA. It is noteworthy, however, that the ameliorating effects of NAC on the disturbance of glutamate, choline, and gut microbiota metabolism may be specific to Gd-DTPA. In all, these findings could be potentially useful to decipher the underlying mechanisms of NAC protective effects from the injury induced by gadolinium-based contrast agents.Keywords
This publication has 48 references indexed in Scilit:
- Innovation Analysis on Postgenomic Biomarkers: Glycomics for Chronic DiseasesOMICS: A Journal of Integrative Biology, 2017
- Betaine chemistry, roles, and potential use in liver diseaseBiochimica et Biophysica Acta (BBA) - General Subjects, 2016
- Role of glycogen phosphorylase in liver glycogen metabolismMolecular Aspects of Medicine, 2015
- Diets supplemented with glutamate or glutamine improve protein retention and modulate gene expression of key enzymes of hepatic metabolism in gilthead seabream (Sparus aurata) juvenilesAquaculture, 2015
- Gender differences in adenine-induced chronic kidney disease and cardiovascular complications in ratsAmerican Journal of Physiology-Renal Physiology, 2014
- Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in HumansCirculation, 2012
- Effects of N-acetylcysteine on renal dysfunction in neonates undergoing the arterial switch operationThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Systems Biological Responses to Chronic Perfluorododecanoic Acid Exposure by Integrated Metabonomic and Transcriptomic StudiesJournal of Proteome Research, 2009
- Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosisEuropean Journal of Radiology, 2008
- Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extractsNature Protocols, 2007